Browse by author
Lookup NU author(s): Dr Sam Tingle, Dr George KourounisORCiD, Professor Colin Wilson
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
© 2025 The Author(s). Clinical Transplantation published by John Wiley & Sons Ltd.Background: Liver transplantation is the definitive treatment for end-stage liver disease and some cancers. The use of livers from donors following pre-donation cardiac arrest (PDCA), especially with prolonged downtime duration, has been limited outside of the US due to fears over inferior outcomes from ischemic injury. However, PDCA may induce ischemic preconditioning, paradoxically improving post-transplant outcomes. We analyzed the impact of PDCA occurrence and downtime duration on liver transplantation. Methods: We used the UNOS registry on adult liver transplantation (2010–2023), and included both donation after brain death (DBD) and donation after circulatory death (DCD) donors. Multivariable regression models were used to analyze the associations. Multiple imputation was used for missing data, and restricted cubic spline modelling to account for non-linear relationships. Results: Among 74,592 recipients, 32,631 (43.7%) received a liver from a PDCA donor. PDCA occurrence was associated with a small improvement in graft survival (aHR = 0.914, 95% Cl = 0.851–0.982). Interaction terms revealed this benefit was more pronounced among the following donor groups: DCD, moderately raised alanine aminotransferase (ALT), short admission-to-donation time and older donors. These novel associations are all in keeping with a preconditioning effect. Increasing PDCA downtime duration was also associated with a small improvement in graft survival (aHR per doubling = 0.953, 95% Cl = 0.917–0.991). Similar associations were seen with secondary outcomes. Conclusions: The use of livers from donors with PDCA, including those with prolonged downtime duration, is a safe and simple approach to expand the donor pool internationally. Interaction terms and non-linear modelling provided clinical evidence for ischemic preconditioning from PDCA, which represents the largest real-world demonstration of this phenomenon.
Author(s): Amarnath DR, Tingle SJ, Kourounis G, Freise C, Roll GR, Yamaguchi S, Rickert C, Wilson CH
Publication type: Article
Publication status: Published
Journal: Clinical Transplantation
Year: 2025
Volume: 39
Issue: 9
Print publication date: 01/09/2025
Online publication date: 09/09/2025
Acceptance date: 29/08/2025
Date deposited: 30/09/2025
ISSN (print): 0902-0063
ISSN (electronic): 1399-0012
Publisher: John Wiley and Sons Inc
URL: https://doi.org/10.1111/ctr.70309
DOI: 10.1111/ctr.70309
Data Access Statement: The data used in the analysis are available from OPTN/UNOS. Data can be requested from OPTN/UNOS through the following website: https://optn.transplant.hrsa.gov/data/view-data-reports/request-data/.
PubMed id: 40924859
Altmetrics provided by Altmetric
